UA107457C2 - Похідні піразолу - Google Patents

Похідні піразолу

Info

Publication number
UA107457C2
UA107457C2 UAA201112488A UAA201112488A UA107457C2 UA 107457 C2 UA107457 C2 UA 107457C2 UA A201112488 A UAA201112488 A UA A201112488A UA A201112488 A UAA201112488 A UA A201112488A UA 107457 C2 UA107457 C2 UA 107457C2
Authority
UA
Ukraine
Prior art keywords
hydrogen atom
halogen atom
substituent
pyrazole derivatives
atom
Prior art date
Application number
UAA201112488A
Other languages
English (en)
Russian (ru)
Inventor
Харуюкі Нішіда
Ікуо Фуджіморі
Original Assignee
Такеда Фармасьютікал Компані Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Такеда Фармасьютікал Компані Лімітед filed Critical Такеда Фармасьютікал Компані Лімітед
Publication of UA107457C2 publication Critical patent/UA107457C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Винахід стосується сполуки, що більш сильно пригнічує секрецію кислоти та має противиразкову дію, тощо. Сполука, представлена формулою EMBED ISISServer , (I) де R1 є замісником, R2 означає (і) атом водню, (іі) С1-6-алкіл, який необов'язково містить атом галогену, або (ііі) ціаногрупу, R3 означає (і) атом водню, (іі) атом галогену, (ііі) ціаногрупу, (iv) С1-6-алкіл, який необов'язково містить атом галогену, або (v) С1-6-алкокси, який необов'язково містить атом галогену, один з R2 та R3 означає атом водню та інший є замісником, що не є атомом водню, або її сіль.
UAA201112488A 2009-03-26 2010-03-25 Похідні піразолу UA107457C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009077078 2009-03-26
PCT/JP2010/055257 WO2010110378A1 (ja) 2009-03-26 2010-03-25 ピラゾール化合物

Publications (1)

Publication Number Publication Date
UA107457C2 true UA107457C2 (uk) 2015-01-12

Family

ID=42781069

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201112488A UA107457C2 (uk) 2009-03-26 2010-03-25 Похідні піразолу

Country Status (25)

Country Link
US (1) US8895588B2 (uk)
EP (1) EP2412713B1 (uk)
JP (1) JP5552481B2 (uk)
KR (1) KR101656906B1 (uk)
CN (1) CN102448953B (uk)
AU (1) AU2010228220B2 (uk)
BR (1) BRPI1009090A2 (uk)
CA (1) CA2756086A1 (uk)
CL (1) CL2011002351A1 (uk)
CO (1) CO6460700A2 (uk)
CR (1) CR20110533A (uk)
DO (1) DOP2011000296A (uk)
EA (1) EA019853B1 (uk)
EC (1) ECSP11011419A (uk)
GE (1) GEP20156222B (uk)
IL (1) IL215235A (uk)
MA (1) MA33214B1 (uk)
MX (1) MX2011009943A (uk)
NZ (1) NZ595890A (uk)
PE (1) PE20120618A1 (uk)
SG (1) SG174476A1 (uk)
TN (1) TN2011000474A1 (uk)
UA (1) UA107457C2 (uk)
WO (1) WO2010110378A1 (uk)
ZA (1) ZA201107435B (uk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201408511QA (en) 2012-06-27 2015-01-29 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
AU2013323349B2 (en) * 2012-09-27 2016-09-15 Aratana Therapeutics, Inc. Compositions and methods of use of an inappetance-controlling compound
WO2016123233A1 (en) 2015-01-28 2016-08-04 Aratana Therapeutics, Inc. Compositions and methods for chronic use of a weight-gaining compound
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285991A (en) 1963-03-26 1966-11-15 Union Carbide Corp Polyepoxides cured with the reaction product of a dihydroxydiphenylsul-fone, an amine, and an aldehyde
US4847289A (en) 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
CN1071924A (zh) 1991-10-29 1993-05-12 纳幕尔杜邦公司 除草的三唑羧酸酰胺
JP3155009B2 (ja) 1994-09-26 2001-04-09 塩野義製薬株式会社 イミダゾール誘導体
JPH0948778A (ja) 1995-08-04 1997-02-18 Sagami Chem Res Center 2−置換−3−アルコキシ−5−(ピロール−2−イル)フラン誘導体
ZA969273B (en) 1995-11-06 1998-05-05 Univ Pittsburgh Inhibitors of protein isoprenyl transferases.
ATE443698T1 (de) 1996-12-23 2009-10-15 Bristol Myers Squibb Pharma Co Stickstoffhaltige heterocyclen als faktor xa- hemmer
WO1999042461A1 (en) 1998-02-23 1999-08-26 Warner-Lambert Company Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
JP2006526015A (ja) 2003-05-02 2006-11-16 エラン ファーマシューティカルズ,インコーポレイテッド 炎症疾患治療のためのブラジキニンb1受容体アンタゴニストとしての4−ブロモ−5−(2−クロロ−ベンゾイルアミノ)−1h−ピラゾール−3−カルボン酸アミド誘導体および関連化合物
ES2351393T3 (es) 2003-05-26 2011-02-03 Takeda Pharmaceutical Company Limited Sulfopirroles.
EP1648455A4 (en) 2003-07-23 2009-03-04 Exelixis Inc MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE
US8048909B2 (en) 2004-09-30 2011-11-01 Takeda Pharmaceutical Company Limited Proton pump inhibitors
JP4035559B1 (ja) * 2005-08-30 2008-01-23 武田薬品工業株式会社 酸分泌抑制薬としての1−ヘテロシクリルスルホニル、2−アミノメチル、5−(ヘテロ−)アリール置換1−h−ピロール誘導体
EP2005957B1 (en) * 2006-03-31 2012-05-30 Takeda Pharmaceutical Company Limited Acid secretion inhibitor
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
JP2009077078A (ja) 2007-09-19 2009-04-09 Brother Ind Ltd 位置検出システム
US20090156642A1 (en) 2007-09-28 2009-06-18 Takeda Pharmaceutical Company Limited 5-Membered heterocyclic compound
WO2009041447A1 (ja) 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited 5員複素環化合物
PE20091846A1 (es) 2008-05-19 2009-12-16 Plexxikon Inc DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
CN102099339A (zh) 2008-07-18 2011-06-15 武田药品工业株式会社 苯并氮杂衍生物及其作为组胺h3拮抗剂的用途

Also Published As

Publication number Publication date
ECSP11011419A (es) 2011-11-30
EP2412713A4 (en) 2014-04-02
NZ595890A (en) 2013-09-27
CN102448953A (zh) 2012-05-09
CR20110533A (es) 2012-02-13
KR101656906B1 (ko) 2016-09-12
CL2011002351A1 (es) 2012-07-13
CA2756086A1 (en) 2010-09-30
IL215235A (en) 2014-07-31
MX2011009943A (es) 2011-10-06
PE20120618A1 (es) 2012-06-05
BRPI1009090A2 (pt) 2016-03-01
GEP20156222B (en) 2015-01-26
EA201171168A1 (ru) 2012-05-30
MA33214B1 (fr) 2012-04-02
SG174476A1 (en) 2011-10-28
AU2010228220B2 (en) 2015-05-21
AU2010228220A1 (en) 2011-11-17
TN2011000474A1 (en) 2013-03-27
JPWO2010110378A1 (ja) 2012-10-04
JP5552481B2 (ja) 2014-07-16
EP2412713A1 (en) 2012-02-01
CN102448953B (zh) 2014-05-07
CO6460700A2 (es) 2012-06-15
EP2412713B1 (en) 2016-11-30
ZA201107435B (en) 2012-08-29
DOP2011000296A (es) 2011-10-15
AU2010228220A2 (en) 2011-11-24
IL215235A0 (en) 2011-12-29
KR20110130483A (ko) 2011-12-05
US8895588B2 (en) 2014-11-25
US20120095057A1 (en) 2012-04-19
WO2010110378A1 (ja) 2010-09-30
EA019853B1 (ru) 2014-06-30

Similar Documents

Publication Publication Date Title
MX2009004920A (es) Nuevos derivados de aminopirimidina como inhibidores de plk1.
MX2011008305A (es) Compuestos de piridazinona.
WO2009069736A1 (ja) 含窒素化合物
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
WO2008108380A3 (en) Pyrrole compounds
MY148703A (en) Polycyclic cinnamide derivatives
MX2013011429A (es) Novedoso compuesto de imidazo-oxazina o sal del mismo.
UA105185C2 (uk) Піроли
MY160443A (en) Nitrogen-containing heterocyclic compound and agricultural fungicide
NZ592497A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
WO2010014930A3 (en) Piperidine derivatives as jak3 inhibitors
NO20073956L (no) Pyrazolderivater for inhibering av CDK og GSK
WO2008129951A1 (ja) 新規なジベンジルアミン構造を有するピリミジン化合物及びこれを含有する医薬
MX2011009146A (es) Sales de adicion de aminas que contienen grupos hidroxilo y/o carboxilicos con derivados de acido aminonicotinico como inhibidores de dhodh.
WO2008140066A3 (en) Pyridone derivatives as p38a mapk inhibitors
MY159870A (en) Piperazine compound capable of inhibiting prostaglandin d synthase
WO2008136444A1 (ja) 縮合複素環誘導体
WO2008126901A1 (ja) 含窒素複素環化合物およびそれを含有する医薬組成物
WO2009118473A3 (fr) Composés dérivés d'azétidines, leur préparation et leur application en thérapeutique
AU2010332955A8 (en) 3,4,4A,10B-tetrahydro-1H-thiopyrano-[4, 3-c] isoquinoline derivatives
EA200700360A1 (ru) Новые производные амида гетероциклической карбоновой кислоты
WO2008136378A1 (ja) 新規なスルホンアミド誘導体またはその塩
UA107457C2 (uk) Похідні піразолу
MX2010010471A (es) Derivado de tetrahidroisoquinolina novedoso.
EA201400078A1 (ru) Микробиоцидные гетероциклы